Astra Taps Roche Exec as New CEO; FDA OKs Gilead's Quad Pill - Aug. 28, 2012

Having trouble viewing this email? View in Browser.

Tuesday, August 28, 2012  |   |   |   |  SSCI Inc., A Division of Aptuit, will be offering "Pharmaceutical Solids: Essential Knowledge and Advanced Concepts," a two-day Pharmaceutical Solids Short Course for drug development scientists and related professionals. This event is designed for those who are looking to expand their knowledge of how solid state chemistry supports drug development, helping them to understand the importance of designing stable drug products early in the process. It will also have valuable information for IP attorneys and others concerned with drug development intellectual property. The two-day course will be held on October 18 and 19 at The Gleacher Center of The University of Chicago, and has been scheduled to coincide with the conclusion of the AAPS Annual Meeting for the convenience of attendees who are drawn to both of these industry events. To learn more and register for the Short Course, please go to http://www.ssci-inc.com/Information/ShortCourses/tabid/195/Default.aspx.   •  AstraZeneca PLC (AZN) Taps Roche (RHHBY) Exec as New CEO More... •  FDA OKs Gilead Sciences, Inc. (GILD)'s Quad Pill More... •  Ex-Google Inc. Workers Start Flatiron Health to Help Fight Cancer More... •  Sanofi (France) (SAN.PA) Recalls Nine Lots of Kidney Transplant Rejection Drug More... •  Alnylam Pharmaceuticals (ALNY) and Monsanto Company (MON) Sign $29.2 Million Agricultural Biotech Deal More... •  AstraZeneca PLC (AZN) Granted Marketing Authorisation in Europe for ZINFORO More... •  Novartis AG (NVS) Gets Approval From European Commission for Jakavi More... •  Caraco Pharmaceutical Laboratories, Ltd. (CPD) Gets FDA Nod to Resume U.S. Operations More... More Top News JAX® In Vivo Pharmacology Services Rely on our unmatched expertise in efficacy studies to accelerate your drug discovery research. Our in vivo pharmacology testing services are fast, flexible, and supported by our 80-year history in mouse-based research. We provide comprehensive, data-driven efficacy testing in a wide range of therapeutic areas: • Oncology • Inflammatory and autoimmune disease • Metabolic disorders • Neuromuscular and neurodegenerative disorders To date, we have performed in vivo studies in over 100 mouse strains, We work closely with you to ensure that any custom protocols are executed to your exact specifications, and have documented success in implementing conventional protocols and adapting the latest procedures from the literature. Please click here for more information. •  Energy Drinks Improve Heart Function, University of Siena Study More... •  How a Virus Might Make You Diabetic Later in Life, Leiden University Medical Center Study More... •  Vitamin B3 May Offer New Tool in Fight Against Staph Infections, "Superbugs," Oregon State University and University of California, Los Angeles (UCLA) Study More... •  New Model of Muscular Dystrophy Provides Insight Into Disease Development, University of Iowa Study More... •  Ohio State University Scientists Find New RNA Phenomenon That Challenges Dogma More... •  Little Evidence Supports Autism Treatment Options in Adolescents, Vanderbilt University Study More... •  Antibiotic Residues in Sausage Meat May Promote Pathogen Survival, University of Copenhagen and University College Cork Study More... •  Why Some Fats are Worse Than Others, University of New Mexico and Northwestern University Study More...   More Featured News Design and Development of Antibodies to Complex Protein Targets for Critical Assay Applications October 3, 2012 Online Webinar: Webinar Begins at 1pm EST. Examination of functional and therapeutic antibody-antigen x-ray crystal structures provides critical insight into B-cell epitope architecture. SDIX Genomic Antibody Technology™ is designed for development of antibodies that recognize conformational epitopes in critical assay formats such as sandwich immunoassays and flow cytometry and, enables targeting of antibodies to specific sites of native proteins. Antigen and antibody design strategies useful for different assay formats and classes of protein targets, including secreted and multipass membrane proteins are discussed. For more information, please visit http://www.sdix.com/learn. • Genetown (Cambridge, Massachusetts) Vertex Associate Director, Clinical Pharmacology Assisting the planning and execution of the Clinical Development Plan for new clinical entities particularly as it applies to the discipline of Clinical Pharmacology. The AD will supervise or conduct clinical studies such as drug-drug interaction, special population or bioavailability, working with Vertex teams. • Genetown (Cambridge, Massachusetts) Vertex Director, Clinical Pharmacology Assisting the planning and execution of the Clinical Development Plan for new clinical entities particularly as it applies to the discipline of Clinical Pharmacology. The Director will supervise or conduct clinical studies such as drug-drug interaction, special population or bioavailability, working with Vertex teams. • Pharm Country (Summit, New Jersey) Celgene Scientist II Will be responsible for well-defined and controlled experiments being mindful of translational relevance. Responsible for experimental design, interpretation of results and making scientific presentations to global project teams and senior management. • Biotech Beach (Santa Monica, California) Astellas Pharma US QC Microbiologist Supervisor Supervise staff, product testing and Environmental Monitoring data within the QC Microbiology department in support of clinical manufacturing. The role will act as a technical expert within the organization with extensive knowledge related to aseptic procedure and compendial testing. • BioMidwest (Chicago, Illinois) Takeda Pharmaceuticals Quality Systems Program Manager Provide a regional resource to lead TGRD US functional teams in the identification and mitigation of systemic issues which may compromise the compliance of Takeda's drug development operations. The person in this position will work with PDD Global Quality Assurance and TGRD US project teams in the quality investigation, deviation and waiver process including root cause analysis, remediation, tracking and documentation. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! 2012 Pharm Country Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Pharm Country Career Fair, Bridgewater, NJ September 13, 2012 • Biotech Beach Career Fair, San Diego, CA September 20, 2012 • Biotech Bay Career Fair, Burlingame, CA October 3, 2012 • BioCapital Career Fair, Bethesda, MD October 9, 2012 • BioMidwest Career Fair, Lincolnshire, IL October 22, 2012 • Bio NC Career Fair, Durham, NC October 25, 2012 • Genetown Career Fair, Cambridge, MA November 5, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 • Evaluate the PFC market in terms of regulatory environment, demand/supply dynamics, market size and structure. •Gain up-to-date information regarding the deals and alliances in the PFC industry and how they affect the major players in this market. • Understand the basic PFC manufacturing processes and the raw materials used in their production. Click Here for More Information. Johnson Matthey Pharma Services 25 Patton Road Devens, Massachusetts 01434 U.S.A. Phone: 978-784-5000 Fax: 978-784-5500 Johnson Matthey Pharma Services (JMPS) provides API outsourcing solutions from discovery through commercial production. Located approximately 35 miles west of the Boston/Cambridge area, our facilities offer a design that incorporates both kilo-labs and pilot plant with expansion opportunity. More Company Profiles FREE Subscription to ALN World ALN World provides the latest updates on international resources, products, and information to design, build, and equip today's research animal facilities. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.